[{"Assets_0_Q3_USD":11310800000.0,"CommonStockDividendsPerShareDeclared_1_Q3_USD":0.21,"EarningsPerShareDiluted_3_Q3_USD":1.21,"EarningsPerShareDiluted_1_Q3_USD":0.67,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":136000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":136000000.0,"EarningsPerShareBasic_3_Q3_USD":1.21,"EarningsPerShareBasic_1_Q3_USD":0.68,"StockholdersEquityConverted_0_Q3_USD":5759100000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":136400000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":136800000.0,"StockholdersEquity_0_Q3_USD":5758800000.0,"NetIncomeLossConverted_3_Q3_USD":165100000.0,"NetIncomeLossConverted_1_Q3_USD":92200000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":298300000.0,"CommonStockSharesConverted_0_Q3_shares":136100000.0,"RevenuesConverted_1_Q3_USD":1191100000.0,"RevenuesConverted_3_Q3_USD":3514600000.0,"Ticker":"PRGO","CIK":"1585364","name":"PERRIGO CO PLC","OfficialName":"Perrigo Company plc Ordinary Shares","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4754722726.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20191106"}]